Uroplasty, Inc. (UPI) Posts Q4 Loss of 3c/Share

Uroplasty, Inc. (NASDAQ: UPI) reported Q4 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $5.51 million.

For earnings history and earnings-related data on Uroplasty, Inc. (UPI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
• Stantec (STN) Tops Q2 EPS by 47c